
COVID-19 Diagnostics Market
Description
The global COVID-19 Diagnostics market was valued at $6.71 billion in 2020 and is projected to reach $10.23 billion by 2028, growing at a CAGR of 1.02% from 2021 to 2028. This growth is driven by several macro and microeconomic factors, including the substantial rise in COVID-19 infections.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Technology (Molecular, Immunoassay, Others)
By Product (PCR Kits, POC Test, Immunoassay Test, Others)
By End-User (Hospitals, Diagnostic Labs, Physician’s office and urgent care clinics, Others)
Key players
Hoffmann-La Roche
Seegene Inc
Cepheid
Mylab Lifesolutions Pvt. Ltd
SureScreen Diagnostics Ltd
Cellex Inc
Genematrix
Thermo Fisher Scientific
Laboratory Corp Of America Holdings
Robert Bosch
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Technology (Molecular, Immunoassay, Others)
By Product (PCR Kits, POC Test, Immunoassay Test, Others)
By End-User (Hospitals, Diagnostic Labs, Physician’s office and urgent care clinics, Others)
Key players
Hoffmann-La Roche
Seegene Inc
Cepheid
Mylab Lifesolutions Pvt. Ltd
SureScreen Diagnostics Ltd
Cellex Inc
Genematrix
Thermo Fisher Scientific
Laboratory Corp Of America Holdings
Robert Bosch
Table of Contents
- Chapter 1. Executive Summary
- Chapter 2. Scope Of The Study
- 2.1. Market Definition
- 2.2. Scope Of The Study
- 2.2.1. Objectives of Report
- Chapter 3. Evolve BI Methodology
- Chapter 4. Market Insights and Trends
- 4.1. Supply/ Value Chain Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Threat Of New Entrants
- 4.2.2. Bargaining Power Of Buyers
- 4.2.3. Bargaining Power Of Suppliers
- 4.2.4. Threat Of Substitutes
- 4.2.5. Industry Rivalry
- 4.3. Impact of COVID-19 on COVID-19 Diagnostics Market
- 4.3.1. Impact on Market Size
- 4.3.2. End User Trend, Preferences, and Budget Impact
- 4.3.3. Regulatory Framework/Government Policies
- 4.3.4. Key Players Strategy to Tackle Negative Impact
- 4.3.5. Opportunity Window
- Chapter 5. Market Dynamics
- 5.1. Introduction
- 5.2. DRO Analysis
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- Chapter 6. Global COVID-19 Diagnostics Market, By Technology
- 6.1. Introduction
- 6.2. Molecular
- 6.3. Immunoassay
- 6.4. Others
- Chapter 7. Global COVID-19 Diagnostics Market, By Product
- 7.1. Introduction
- 7.2. PCR Kits
- 7.3. POC Test
- 7.4. Immunoassay Test
- 7.5. Others
- Chapter 8. Global COVID-19 Diagnostics Market, By End-User
- 8.1. Introduction
- 8.2. Hospitals
- 8.3. Diagnostic Labs
- 8.4. Physician's office and urgent care clinics
- 8.5. Others
- Chapter 9. Global COVID-19 Diagnostics Market, By Region
- 9.1. Introduction
- 9.2. North America
- 9.2.1. Introduction
- 9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.2.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.2.5. Market Size and Forecast, By Product, 2020 - 2028
- 9.2.6. Market Size and Forecast, By End-User, 2020 - 2028
- 9.2.7. US
- 9.2.7.1. Introduction
- 9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.7.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.2.7.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.2.7.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.2.8. Canada
- 9.2.8.1. Introduction
- 9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.8.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.2.8.5. Market Size and Forecast, By Product, 2020 - 2028
- 9.2.8.6. Market Size and Forecast, By End-User, 2020 - 2028
- 9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.3.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.5. Market Size and Forecast, By Product, 2020 - 2028
- 9.3.6. Market Size and Forecast, By End-User, 2020 - 2028
- 9.3.7. Germany
- 9.3.7.1. Introduction
- 9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.7.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.7.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.3.7.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.3.8. France
- 9.3.8.1. Introduction
- 9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.8.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.8.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.3.8.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.3.9. UK
- 9.3.9.1. Introduction
- 9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.9.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.9.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.3.9.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.3.10. Italy
- 9.3.10.1. Introduction
- 9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.10.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.10.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.3.10.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.3.11. Rest Of Europe
- 9.3.11.1. Introduction
- 9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.11.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.11.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.3.11.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.4. Asia-Pacific
- 9.4.1. Introduction
- 9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.4.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.5. Market Size and Forecast, By Product, 2020 - 2028
- 9.4.7. Market Size and Forecast, By End-User, 2020 - 2028
- 9.4.8. China
- 9.4.8.1. Introduction
- 9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.8.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.8.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.4.8.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.4.9. India
- 9.4.9.1. Introduction
- 9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.9.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.9.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.4.9.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.4.10. Japan
- 9.4.10.1. Introduction
- 9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.10.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.10.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.4.10.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.4.11. South Korea
- 9.4.11.1. Introduction
- 9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.11.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.11.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.4.11.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.4.12. Rest Of Asia-Pacific
- 9.4.11.1. Introduction
- 9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.12.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.12.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.4.12.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.5. Rest Of The World (RoW)
- 9.5.1. Introduction
- 9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.5.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.5.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.5.6. Market Size and Forecast, By Region, 2020 - 2028
- 9.5.7. South America
- 9.5.7.1. Introduction
- 9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.7.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.5.7.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.5.7.5. Market Size and Forecast, By End-User, 2020 - 2028
- 9.5.8. Middle East & Africa
- 9.5.8.1. Introduction
- 9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.8.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.5.8.4. Market Size and Forecast, By Product, 2020 - 2028
- 9.5.8.5. Market Size and Forecast, By End-User, 2020 - 2028
- Chapter 10. Competitive Landscape
- 10.1. Introduction
- 10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
- Chapter 11. Company Profiles
- 11.1. F. Hoffmann-La Roche
- 11.1.1. Business Overview
- 11.1.2. Financial Analysis
- 11.1.3. Product Portfolio
- 11.1.4. Recent Development and Strategies Adopted
- 11.1.5. SWOT Analysis
- 11.2. Seegene Inc
- 11.2.1. Business Overview
- 11.2.2. Financial Analysis
- 11.2.3. Product Portfolio
- 11.2.4. Recent Development and Strategies Adopted
- 11.2.5. SWOT Analysis
- 11.3. Cepheid
- 11.3.1. Business Overview
- 11.3.2. Financial Analysis
- 11.3.3. Product Portfolio
- 11.3.4. Recent Development and Strategies Adopted
- 11.3.5. SWOT Analysis
- 11.4. Mylab Lifesolutions Pvt. Ltd
- 11.4.1. Business Overview
- 11.4.2. Financial Analysis
- 11.4.3. Product Portfolio
- 11.4.4. Recent Development and Strategies Adopted
- 11.4.5. SWOT Analysis
- 11.5. SureScreen Diagnostics Ltd
- 11.5.1. Business Overview
- 11.5.2. Financial Analysis
- 11.5.3. Product Portfolio
- 11.5.4. Recent Development and Strategies Adopted
- 11.5.5. SWOT Analysis
- 11.6. Cellex Inc
- 11.6.1. Business Overview
- 11.6.2. Financial Analysis
- 11.6.3. Product Portfolio
- 11.6.4. Recent Development and Strategies Adopted
- 11.6.5. SWOT Analysis
- 11.7. Genematrix
- 11.7.1. Business Overview
- 11.7.2. Financial Analysis
- 11.7.3. Product Portfolio
- 11.7.4. Recent Development and Strategies Adopted
- 11.7.5. SWOT Analysis
- 11.8. Thermo Fisher Scientific
- 11.8.1. Business Overview
- 11.8.2. Financial Analysis
- 11.8.3. Product Portfolio
- 11.8.4. Recent Development and Strategies Adopted
- 11.8.5. SWOT Analysis
- 11.9. Laboratory Corp Of America Holdings
- 11.9.1. Business Overview
- 11.9.2. Financial Analysis
- 11.9.3. Product Portfolio
- 11.9.4. Recent Development and Strategies Adopted
- 11.9.5. SWOT Analysis
- 11.10. Robert Bosch
- 11.10.1. Business Overview
- 11.10.2. Financial Analysis
- 11.10.3. Product Portfolio
- 11.9.4. Recent Development and Strategies Adopted
- 11.9.5. SWOT Analysis
- Chapter 12. Key Takeaways
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.